Clinical Trials Insight: 700027999

Trial Profile

Clinical Trials Insight: 700027999

Phase of Trial: Phase III

Latest Information Update: 24 Oct 2008

At a glance

  • Drugs Tezampanel (Primary)
  • Indications Migraine
  • Focus Therapeutic Use
  • Sponsors TorreyPines Therapeutics Inc
  • Most Recent Events

    • 24 Oct 2008 US FDA agreed that TorreyPines Therapeutics may initiate phase III program for tezampanel in acute migraine, according to TorreyPines Therapeutics media release.
    • 29 Sep 2008 An end of phase II meeting with the US FDA conducted to discuss the phase III program for tezampanel in acute migraine headache.
    • 31 Oct 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top